Cancer Research Meeting Calendar Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Usadel, H.
Right arrow Articles by Sidransky, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Usadel, H.
Right arrow Articles by Sidransky, D.
[Cancer Research 62, 371-375, January 15, 2002]
© 2002 American Association for Cancer Research

Advances in Brief

Quantitative Adenomatous Polyposis Coli Promoter Methylation Analysis in Tumor Tissue, Serum, and Plasma DNA of Patients with Lung Cancer1

Henning Usadel, Jan Brabender, Kathy D. Danenberg, Carmen Jerónimo, Susan Harden, James Engles, Peter V. Danenberg, Stephen Yang and David Sidransky2

Departments of Otolaryngology-Head and Neck Surgery, Head and Neck Cancer Research Division [H. U., C. J., S. H., J. E., D. S.] and Thoracic Surgery [S. Y.], Johns Hopkins University School of Medicine, Baltimore Maryland 21205-2196, and Department of Biochemistry and Molecular Biology and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California 90033 [J. B., K. D. D., P. V. D.]

The serum of cancer patients often harbors increased free DNA levels, which can potentially be used for cancer detection. Because genetic and epigenetic alterations of the adenomatous polyposis coli (APC) gene are common events in gastrointestinal tumor development, we sought to investigate the frequency and level of aberrant APC promoter methylation in primary tumors and paired preoperative serum or plasma samples of lung cancer patients by semiquantitative methylation-specific fluorogenic real-time PCR. We detected methylation of APC in 95 of 99 (96%) primary lung cancer tissues. Forty-two of 89 (47%) available serum and/or plasma samples from these cases carried detectable amounts of methylated APC promoter DNA. In contrast, no methylated APC promoter DNA was detected in serum samples from 50 healthy controls. A highly elevated APC methylation level in lung cancer tissue was the only independent factor predicting inferior survival in this cohort (P = 0.015). APC methylation analysis appears to be promising as a prognostic factor in primary lung cancer and as a noninvasive tumor marker in plasma and/or serum DNA.




This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
G. Sozzi, L. Roz, D. Conte, L. Mariani, F. Andriani, S. Lo Vullo, C. Verri, and U. Pastorino
Plasma DNA Quantification in Lung Cancer Computed Tomography Screening: Five-Year Results of a Prospective Study
Am. J. Respir. Crit. Care Med., January 1, 2009; 179(1): 69 - 74.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
N. Shivapurkar, V. Stastny, Y. Xie, C. Prinsen, E. Frenkel, B. Czerniak, F. B. Thunnissen, J. D. Minna, and A. F. Gazdar
Differential Methylation of a Short CpG-Rich Sequence within Exon 1 of TCF21 Gene: A Promising Cancer Biomarker Assay
Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 995 - 1000.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. L. Carvalho, C. Jeronimo, M. M. Kim, R. Henrique, Z. Zhang, M. O. Hoque, S. Chang, M. Brait, C. S. Nayak, W.-W. Jiang, et al.
Evaluation of Promoter Hypermethylation Detection in Body Fluids as a Screening/Diagnosis Tool for Head and Neck Squamous Cell Carcinoma
Clin. Cancer Res., January 1, 2008; 14(1): 97 - 107.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. S. Kim, K. Yamashita, Y. K. Chae, Y. Tokumaru, X. Chang, M. Zahurak, M. Osada, H. L. Park, A. Chuang, J. A. Califano, et al.
A Promoter Methylation Pattern in the N-Methyl-D-Aspartate Receptor 2B Gene Predicts Poor Prognosis in Esophageal Squamous Cell Carcinoma
Clin. Cancer Res., November 15, 2007; 13(22): 6658 - 6665.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. Henrique, F. R. Ribeiro, D. Fonseca, M. O. Hoque, A. L. Carvalho, V. L. Costa, M. Pinto, J. Oliveira, M. R. Teixeira, D. Sidransky, et al.
High Promoter Methylation Levels of APC Predict Poor Prognosis in Sextant Biopsies from Prostate Cancer Patients
Clin. Cancer Res., October 15, 2007; 13(20): 6122 - 6129.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Kagan, S. Srivastava, P. E. Barker, S. A. Belinsky, and P. Cairns
Towards Clinical Application of Methylated DNA Sequences as Cancer Biomarkers: A Joint NCI's EDRN and NIST Workshop on Standards, Methods, Assays, Reagents and Tools
Cancer Res., May 15, 2007; 67(10): 4545 - 4549.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
K. Munson, J. Clark, K. Lamparska-Kupsik, and S. S. Smith
Recovery of bisulfite-converted genomic sequences in the methylation-sensitive QPCR
Nucleic Acids Res., May 14, 2007; 35(9): 2893 - 2903.
[Abstract] [Full Text] [PDF]

Home page
 aacredbookHome page
P. Cairns
Measurements of Gene Methylation in Cancer
Am. Assoc. Cancer Res. Educ. Book, April 14, 2007; 2007(1): 189 - 193.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. A. Righini, F. de Fraipont, J.-F. Timsit, C. Faure, E. Brambilla, E. Reyt, and M.-C. Favrot
Tumor-Specific Methylation in Saliva: A Promising Biomarker for Early Detection of Head and Neck Cancer Recurrence
Clin. Cancer Res., February 15, 2007; 13(4): 1179 - 1185.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
F. Model, N. Osborn, D. Ahlquist, R. Gruetzmann, B. Molnar, F. Sipos, O. Galamb, C. Pilarsky, H.-D. Saeger, Z. Tulassay, et al.
Identification and Validation of Colorectal Neoplasia-Specific Methylation Markers for Accurate Classification of Disease
Mol. Cancer Res., February 1, 2007; 5(2): 153 - 163.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Widschwendter and U. Menon
Circulating Methylated DNA: A New Generation of Tumor Markers
Clin. Cancer Res., December 15, 2006; 12(24): 7205 - 7208.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. Gu, D. Berman, C. Lu, I. I. Wistuba, J. A. Roth, M. Frazier, M. R. Spitz, and X. Wu
Aberrant Promoter Methylation Profile and Association with Survival in Patients with Non-Small Cell Lung Cancer
Clin. Cancer Res., December 15, 2006; 12(24): 7329 - 7338.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. K. Pathak, M. Bhutani, S. Kumar, A. Mohan, and R. Guleria
Circulating Cell-Free DNA in Plasma/Serum of Lung Cancer Patients as a Potential Screening and Prognostic Tool
Clin. Chem., October 1, 2006; 52(10): 1833 - 1842.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. O. Hoque, Q. Feng, P. Toure, A. Dem, C. W. Critchlow, S. E. Hawes, T. Wood, C. Jeronimo, E. Rosenbaum, J. Stern, et al.
Detection of Aberrant Methylation of Four Genes in Plasma DNA for the Detection of Breast Cancer
J. Clin. Oncol., September 10, 2006; 24(26): 4262 - 4269.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Foltz, G.-Y. Ryu, J.-G. Yoon, T. Nelson, J. Fahey, A. Frakes, H. Lee, L. Field, K. Zander, Z. Sibenaller, et al.
Genome-Wide Analysis of Epigenetic Silencing Identifies BEX1 and BEX2 as Candidate Tumor Suppressor Genes in Malignant Glioma.
Cancer Res., July 1, 2006; 66(13): 6665 - 6674.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. S. Kim, K. Yamashita, J. H. Baek, H. L. Park, A. L. Carvalho, M. Osada, M. O. Hoque, S. Upadhyay, M. Mori, C. Moon, et al.
N-methyl-D-aspartate receptor type 2B is epigenetically inactivated and exhibits tumor-suppressive activity in human esophageal cancer.
Cancer Res., April 1, 2006; 66(7): 3409 - 3418.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Yamashita, H. L. Park, M. S. Kim, M. Osada, Y. Tokumaru, H. Inoue, M. Mori, and D. Sidransky
PGP9.5 Methylation in Diffuse-Type Gastric Cancer.
Cancer Res., April 1, 2006; 66(7): 3921 - 3927.
[Abstract] [Full Text] [PDF]

Home page
 aacredbookHome page
P. Cairns
Serum-Based Detection of Gene Hypermethylation in Cancers of the Breast and Ovary
Am. Assoc. Cancer Res. Educ. Book, April 1, 2006; 2006(1): 202 - 204.
[Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
R. M. Brena, H. Auer, K. Kornacker, B. Hackanson, A. Raval, J. C. Byrd, and C. Plass
Accurate quantification of DNA methylation using combined bisulfite restriction analysis coupled with the Agilent 2100 Bioanalyzer platform
Nucleic Acids Res., February 7, 2006; 34(3): e17 - e17.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
P. Schatz, J. Distler, K. Berlin, and M. Schuster
Novel method for high throughput DNA methylation marker evaluation using PNA-probe library hybridization and MALDI-TOF detection.
Nucleic Acids Res., January 1, 2006; 34(8): e59 - e59.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
R. Henrique, C. Jeronimo, M. R. Teixeira, M. O. Hoque, A. L. Carvalho, I. Pais, F. R. Ribeiro, J. Oliveira, C. Lopes, and D. Sidransky
Epigenetic Heterogeneity of High-Grade Prostatic Intraepithelial Neoplasia: Clues for Clonal Progression in Prostate Carcinogenesis
Mol. Cancer Res., January 1, 2006; 4(1): 1 - 8.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. Rosenbaum, M. O. Hoque, Y. Cohen, M. Zahurak, M. A. Eisenberger, J. I. Epstein, A. W. Partin, and D. Sidransky
Promoter Hypermethylation as an Independent Prognostic Factor for Relapse in Patients with Prostate Cancer Following Radical Prostatectomy
Clin. Cancer Res., December 1, 2005; 11(23): 8321 - 8325.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
V. Schmiemann, A. Bocking, M. Kazimirek, A. S. C. Onofre, H. E. Gabbert, R. Kappes, C. D. Gerharz, and H. J. Grote
Methylation Assay for the Diagnosis of Lung Cancer on Bronchial Aspirates: A Cohort Study
Clin. Cancer Res., November 1, 2005; 11(21): 7728 - 7734.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. V. Brock, C. M. Hooker, R. Yung, M. Guo, Y. Han, S. E. Ames, D. Chang, S. C. Yang, D. Mason, M. Sussman, et al.
Can We Improve the Cytologic Examination of Malignant Pleural Effusions Using Molecular Analysis?
Ann. Thorac. Surg., October 1, 2005; 80(4): 1241 - 1247.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. O. Hoque, O. Topaloglu, S. Begum, R. Henrique, E. Rosenbaum, W. Van Criekinge, W. H. Westra, and D. Sidransky
Quantitative Methylation-Specific Polymerase Chain Reaction Gene Patterns in Urine Sediment Distinguish Prostate Cancer Patients From Control Subjects
J. Clin. Oncol., September 20, 2005; 23(27): 6569 - 6575.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
K. Miyamoto and T. Ushijima
Diagnostic and Therapeutic Applications of Epigenetics
Jpn. J. Clin. Oncol., June 1, 2005; 35(6): 293 - 301.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. L. Mandelker, K. Yamashita, Y. Tokumaru, K. Mimori, D. L. Howard, Y. Tanaka, A. L. Carvalho, W.-W. Jiang, H. L. Park, M. S. Kim, et al.
PGP9.5 Promoter Methylation Is an Independent Prognostic Factor for Esophageal Squamous Cell Carcinoma
Cancer Res., June 1, 2005; 65(11): 4963 - 4968.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
H. Yang, K. Yang, A. Khafagi, Y. Tang, T. E. Carey, A. W. Opipari, R. Lieberman, P. A. Oeth, W. Lancaster, H. P. Klinger, et al.
Sensitive detection of human papillomavirus in cervical, head/neck, and schistosomiasis-associated bladder malignancies
PNAS, May 24, 2005; 102(21): 7683 - 7688.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Temam, J. Benard, C. Dugas, M. Trassard, E. Gormally, J.-C. Soria, S. Faivre, B. Luboinski, P. Marandas, P. Hainaut, et al.
Molecular Detection of Early-Stage Laryngopharyngeal Squamous Cell Carcinomas
Clin. Cancer Res., April 1, 2005; 11(7): 2547 - 2551.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C.-N. Qian, J. Knol, P. Igarashi, F. Lin, U. Zylstra, B. T. Teh, and B. O. Williams
Cystic Renal Neoplasia Following Conditional Inactivation of Apc in Mouse Renal Tubular Epithelium
J. Biol. Chem., February 4, 2005; 280(5): 3938 - 3945.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Fujiwara, N. Fujimoto, M. Tabata, K. Nishii, K. Matsuo, K. Hotta, T. Kozuki, M. Aoe, K. Kiura, H. Ueoka, et al.
Identification of Epigenetic Aberrant Promoter Methylation in Serum DNA Is Useful for Early Detection of Lung Cancer
Clin. Cancer Res., February 1, 2005; 11(3): 1219 - 1225.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. Jeronimo, R. Henrique, M. O. Hoque, E. Mambo, F. R. Ribeiro, G. Varzim, J. Oliveira, M. R. Teixeira, C. Lopes, and D. Sidransky
A Quantitative Promoter Methylation Profile of Prostate Cancer
Clin. Cancer Res., December 15, 2004; 10(24): 8472 - 8478.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
P. M. Das and R. Singal
DNA Methylation and Cancer
J. Clin. Oncol., November 15, 2004; 22(22): 4632 - 4642.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
O. Gautschi, C. Bigosch, B. Huegli, M. Jermann, A. Marx, E. Chasse, D. Ratschiller, W. Weder, M. Joerger, D. C. Betticher, et al.
Circulating Deoxyribonucleic Acid As Prognostic Marker in Non-Small-Cell Lung Cancer Patients Undergoing Chemotherapy
J. Clin. Oncol., October 15, 2004; 22(20): 4157 - 4164.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
N. J. Belshaw, G. O. Elliott, E. A. Williams, D. M. Bradburn, S. J. Mills, J. C. Mathers, and I. T. Johnson
Use of DNA from Human Stools to Detect Aberrant CpG Island Methylation of Genes Implicated in Colorectal Cancer
Cancer Epidemiol. Biomarkers Prev., September 1, 2004; 13(9): 1495 - 1501.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Tokumaru, K. Yamashita, M. Osada, S. Nomoto, D.-I. Sun, Y. Xiao, M. O. Hoque, W. H. Westra, J. A. Califano, and D. Sidransky
Inverse Correlation between Cyclin A1 Hypermethylation and p53 Mutation in Head and Neck Cancer Identified by Reversal of Epigenetic Silencing
Cancer Res., September 1, 2004; 64(17): 5982 - 5987.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y. Tokumaru, S. V. Harden, D.-I. Sun, K. Yamashita, J. I. Epstein, and D. Sidransky
Optimal Use of a Panel of Methylation Markers with GSTP1 Hypermethylation in the Diagnosis of Prostate Adenocarcinoma
Clin. Cancer Res., August 15, 2004; 10(16): 5518 - 5522.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
N. Reesink-Peters, G. B. A. Wisman, C. Jeronimo, C. Y. Tokumaru, Y. Cohen, S. M. Dong, H. G. Klip, H. J. Buikema, A. J.H. Suurmeijer, H. Hollema, et al.
Detecting Cervical Cancer by Quantitative Promoter Hypermethylation Assay on Cervical Scrapings: A Feasibility Study
Mol. Cancer Res., May 1, 2004; 2(5): 289 - 295.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
O. Topaloglu, M. O. Hoque, Y. Tokumaru, J. Lee, E. Ratovitski, D. Sidransky, and C.-s. Moon
Detection of Promoter Hypermethylation of Multiple Genes in the Tumor and Bronchoalveolar Lavage of Patients with Lung Cancer
Clin. Cancer Res., April 1, 2004; 10(7): 2284 - 2288.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. V. Harden, D. C. Thomas, N. Benoit, K. Minhas, W. H. Westra, J. A. Califano, W. Koch, and D. Sidransky
Real-Time Gap Ligase Chain Reaction: A Rapid Semiquantitative Assay for Detecting p53 Mutation at Low Levels in Surgical Margins and Lymph Nodes from Resected Lung and Head and Neck Tumors
Clin. Cancer Res., April 1, 2004; 10(7): 2379 - 2385.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Widschwendter, H. M. Muller, H. Fiegl, L. Ivarsson, A. Wiedemair, E. Muller-Holzner, G. Goebel, C. Marth, and M. Widschwendter
DNA Methylation in Serum and Tumors of Cervical Cancer Patients
Clin. Cancer Res., January 15, 2004; 10(2): 565 - 571.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
S. E. Cottrell, J. Distler, N. S. Goodman, S. H. Mooney, A. Kluth, A. Olek, I. Schwope, R. Tetzner, H. Ziebarth, and K. Berlin
A real-time PCR assay for DNA-methylation using methylation-specific blockers
Nucleic Acids Res., January 13, 2004; 32(1): e10 - e10.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
Genetic and Epigenetic Alterations in Cancer Detection: DAVID SIDRANSKY, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205-2196
Toxicol Pathol, January 1, 2004; 32(1): 138 - 139.
[PDF]

Home page
 NEJMHome page
J. G. Herman and S. B. Baylin
Gene Silencing in Cancer in Association with Promoter Hypermethylation
N. Engl. J. Med., November 20, 2003; 349(21): 2042 - 2054.
[Full Text] [PDF]

Home page
 JCOHome page
G. Sozzi, D. Conte, M. Leon, R. Cirincione, L. Roz, C. Ratcliffe, E. Roz, N. Cirenei, M. Bellomi, G. Pelosi, et al.
Quantification of Free Circulating DNA As a Diagnostic Marker in Lung Cancer
J. Clin. Oncol., November 1, 2003; 21(21): 3902 - 3908.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
P. A. Bunn Jr
Early Detection of Lung Cancer Using Serum RNA or DNA Markers: Ready for """Prime Time""" or for Validation?
J. Clin. Oncol., November 1, 2003; 21(21): 3891 - 3893.
[Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
H. Li, L. Myeroff, D. Smiraglia, M. F. Romero, T. P. Pretlow, L. Kasturi, J. Lutterbaugh, R. M. Rerko, G. Casey, J.-P. Issa, et al.
SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers
PNAS, July 8, 2003; 100(14): 8412 - 8417.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
A O-O Chan, S-K Lam, B C-Y Wong, W-M Wong, M-F Yuen, Y-H Yeung, W-M Hui, A Rashid, and Y-L Kwong
Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer
Gut, April 1, 2003; 52(4): 502 - 506.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. V. Harden, Y. Tokumaru, W. H. Westra, S. Goodman, S. A. Ahrendt, S. C. Yang, and D. Sidransky
Gene Promoter Hypermethylation in Tumors and Lymph Nodes of Stage I Lung Cancer Patients
Clin. Cancer Res., April 1, 2003; 9(4): 1370 - 1375.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. Brabender, H. Usadel, R. Metzger, P. M. Schneider, J. Park, D. Salonga, D. D. Tsao-Wei, S. Groshen, R. V. Lord, N. Takebe, et al.
Quantitative O6-Methylguanine DNA Methyltransferase Methylation Analysis in Curatively Resected Non-Small Cell Lung Cancer: Associations with Clinical Outcome
Clin. Cancer Res., January 1, 2003; 9(1): 223 - 227.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. C. Chan, S. Y. Lam, K. W. Tsang, B. Lam, J. C. M. Ho, K. H. Fu, W. K. Lam, and Y. L. Kwong
Aberrant Promoter Methylation in Chinese Patients with Non-Small Cell Lung Cancer: Patterns in Primary Tumors and Potential Diagnostic Application in Bronchoalevolar Lavage
Clin. Cancer Res., December 1, 2002; 8(12): 3741 - 3746.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
S. Zochbauer-Muller, J. D. Minna, and A. F. Gazdar
Aberrant DNA Methylation in Lung Cancer: Biological and Clinical Implications
Oncologist, October 1, 2002; 7(5): 451 - 457.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.